Urologix Inc
Urologix, Inc. develops, manufactures, markets, and distributes minimally invasive medical products for the treatment of obstruction and symptoms due to benign prostatic hyperplasia (BPH) in the United States. The company offers Cooled ThermoTherapy, which produces targeted microwave energy combined with a cooling mechanism to protect healthy tissue and enhance patient comfort. It also provides P… Read more
Urologix Inc (ULGX) - Total Assets
Latest total assets as of March 2015: $5.02 Million USD
Based on the latest financial reports, Urologix Inc (ULGX) holds total assets worth $5.02 Million USD as of March 2015.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Urologix Inc - Total Assets Trend (1995–2014)
This chart illustrates how Urologix Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Urologix Inc - Asset Composition Analysis
Current Asset Composition (June 2014)
Urologix Inc's total assets of $5.02 Million consist of 64.9% current assets and 35.1% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 12.7% |
| Accounts Receivable | $1.50 Million | 26.5% |
| Inventory | $1.40 Million | 24.7% |
| Property, Plant & Equipment | $471.00K | 8.3% |
| Intangible Assets | $1.37 Million | 24.2% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (1995–2014)
This chart illustrates how Urologix Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Urologix Inc's current assets represent 64.9% of total assets in 2014, a decrease from 85.7% in 1995.
- Cash Position: Cash and equivalents constituted 12.7% of total assets in 2014, down from 26.5% in 1995.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 24.0% of total assets, an increase from 0.0% in 1995.
- Asset Diversification: The largest asset category is accounts receivable at 26.5% of total assets.
Urologix Inc Competitors by Total Assets
Key competitors of Urologix Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Urologix Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Urologix Inc generates 2.51x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Urologix Inc is currently not profitable relative to its asset base.
Urologix Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.56 | 0.92 | 4.37 |
| Quick Ratio | 0.34 | 0.63 | 3.61 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-2.73 Million | $ -339.00K | $ 6.72 Million |
Urologix Inc - Advanced Valuation Insights
This section examines the relationship between Urologix Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -54.8% |
| Total Assets | $5.67 Million |
| Market Capitalization | $0.98 USD |
Valuation Analysis
Below Book Valuation: The market values Urologix Inc's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Urologix Inc's assets decreased by 54.8% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Urologix Inc (1995–2014)
The table below shows the annual total assets of Urologix Inc from 1995 to 2014.
| Year | Total Assets | Change |
|---|---|---|
| 2014-06-30 | $5.67 Million | -54.76% |
| 2013-06-30 | $12.53 Million | -1.18% |
| 2012-06-30 | $12.68 Million | +87.43% |
| 2011-06-30 | $6.76 Million | -33.72% |
| 2010-06-30 | $10.20 Million | -15.96% |
| 2009-06-30 | $12.14 Million | -30.54% |
| 2008-06-30 | $17.48 Million | -46.47% |
| 2007-06-30 | $32.65 Million | -25.62% |
| 2006-06-30 | $43.90 Million | +12.25% |
| 2005-06-30 | $39.11 Million | +8.11% |
| 2004-06-30 | $36.17 Million | +0.86% |
| 2003-06-30 | $35.86 Million | -22.77% |
| 2002-06-30 | $46.44 Million | -0.90% |
| 2001-06-30 | $46.86 Million | +46.64% |
| 2000-06-30 | $31.96 Million | -18.06% |
| 1999-06-30 | $39.00 Million | -27.10% |
| 1998-06-30 | $53.50 Million | +50.28% |
| 1997-06-30 | $35.60 Million | -16.04% |
| 1996-06-30 | $42.40 Million | +765.31% |
| 1995-06-30 | $4.90 Million | -- |